In vitro and in vivo effects of phenolic antioxidants against cisplatin-induced nephrotoxicity

Journal of Biochemistry

Volumn 125, Issue 2, 1999, Pages 383-390

  Rao, Mahadev ^a   Kumar, Mavinekere Marulapppa ^b   Rao, Mysore Ananthanarayana ^a,c  

^a MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

^b Indian Institute of Animal Health and Veterinary Biologicals   (India)

^c Industrial Estate   (India)

Author keywords

Cisplatin; Cytotoxicity; Free radicals; Nephrotoxicity; Phenolic antioxidants

Indexed keywords

4 AMINOHIPPURIC ACID; ANTIOXIDANT; CISPLATIN; CREATININE; DEHYDROZINGERONE; EUGENOL; GLUTATHIONE; ISOEUGENOL; PHENOL DERIVATIVE; SCAVENGER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOTOXICITY; KIDNEY CORTEX SLICE; MALE; NEPHROTOXICITY; NONHUMAN; RAT; UREA NITROGEN BLOOD LEVEL; VERO CELL;

EID: 0032991634     PISSN: 0021924X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.jbchem.a022298     Document Type: Article

References (39)

1. Rozencweig, M., von Hoff, D.D., Slavil, M., and Muggia, F.M. (1977) cis-Diamine-dichloroplatinum (II). A new anticancer agent. Ann. Intern. Med. 86, 803-809
2. Madias, N.E. and Harrington, S.T. (1978) Platinum nephrotoxicity. Am. J. Med. 65, 307-314
3. Goldstern, R.S. and Mayor, G.H. (1983) The nephrotoxicity of cisplatin. Life Sci. 32, 685-690
4. McGinness, J.E., Proctor, P.H., Demopaulos, H.B., Hockanson, J.A., and Kirckapatrick, D.S. (1978) Amelioration of cisplatinum nephrotoxicity by orgotein (superoxide dismutase). Physiol. Chem. Phys. 10, 267-272
5. Sugihara, K., Nakano, S., Koda, M., Tanaka, K., Fukuishi, N., and Gemba, M. (1987) Stimulatory effect of cisplatin on lipid peroxidation in renal tissues. Jpn. J. Pharmacol. 43, 247-252
6. Baldew, G.S., van den Hamer, C.J.A., Los, G., Vermuelen, N.P.E., de Goeij, J.J.M., and McVie, J.G. (1989) Selenium induced protection against cis-diaminedichloroplatinum nephrotoxicity in mice and rats. Cancer Res. 49, 3020-3023
7. Bompart, G. (1989) Cisplatin-induced changes in cytochrome P 450, lipid peroxidation and drug-metabolizing enzyme activities in rat kidney cortex. Toxicol. Lett. 48, 193-199
8. Zhong, L.F., Zhang, G., Zhang, M., Ma, S.L., and Xia, Y.X. (1990) Protection against cisplatin-induced lipid peroxidation and kidney damage by procaine in rats. Arch. Toxicol. 64, 599-600
9. Zhang, J.G. and Lindup, W.E. (1993) Role of mitochondria in cisplatin-induced oxidative damage exhibited by rat renal cortical slices. Biochem. Pharmacol. 45, 2215-2222
10. Rao, M. and Rao, M.N.A. (1998) Protective effects of cystone, a polyherbal ayurvedic preparation, on cisplatin-induced renal toxicity in rats. J. Ethnopharmacol. 62, 1-6
11. Inselmann, G., Blöhmer, A., Kottny, W., Nellessen, U., Hänel, H., and Heidmann, H.T. (1995) Modification of cisplatin induced renal p-aminohippurate uptake alteration and lipid peroxidation by thiols, Ginkgo biloba extract, desferroxamine and torbafylline. Nephron 70, 425-429
12. Rao, M. and Rao, M.N.A. (1998) Protective effects of selenomethionine against cisplatin-induced renal toxicity in mice and rats. J. Pharm. Pharmacol. 50, 687-691
13. Hu, Y.J., Chen, Y., Zhang, Y.Q., Zhou, M.Z., Song, X.M., Zhang, B.Z., Luo, L., Xu, P.M., Zhao, Y.N., Zhao, Y.B., and Cheng, G. (1997) The protective role of selenium on the toxicity of cisplatin-induced chemotherapy regimen in cancer patients. Biol. Trace Elem. Res. 56, 331-341
14. Dobyan, D.C., Bull, J.M.C., Strebel, F.R., Sunderland, B.A., and Bulger, R.E, (1986) Protective effects of O-(β-hydroxyethyl)-rutoside on cis-platinum-induced acute renal failure in the rat. Lab. Invest. 55, 557-563
15. Atal, C.K. and Kapur, B.M. (1989) in Cultivation and Utilisation of Aromatic Plants, p. 85, Publication: RRI, (CSIR) Jammu Tawi
16. Nagababu, E. and Lakshmaiah, N. (1992) Inhibitory effect of eugenol on non-enzymatic lipid peroxidation in rat liver mitochondria. Biochem. Pharmacol. 43, 2393-2400
17. Rajkumar, D.V. and Rao, M.N.A. (1993) Dehydrozingerone and isoeugenol as inhibitors of lipid peroxidation and as free radical scavengers. Biochem. Pharmacol. 46, 2067-2072
18. Singh, G.B., Leach, G.D.H., and Atal, C.K. (1987) Antiinflammatory actions of methyl-and phenyl-3-methoxy-4-hydroxy styryl ketones. Arzneim. Forsch. Drug Res. 37, 435-440
19. Elias, G. and Rao, M.N.A. (1988) Synthesis and antiinflammatory activity of substituted (E)-4-phenyl-3-buten-2-ones. Eur. J. Med. Chem. 23, 379-380
20. Saldanha, L.A., Elias, G., and Rao, M.N.A. (1990) Oxygen radical scavenging activity of phenylbutenones and their correlation with antiinflammatory activity. Arzneim. Forsch. Drug Res. 40, 89-91
21. Rajkumar, D.V. and Rao, M.N.A. (1994) Antioxidant properties of dehydrozingerone and curcumin in rat brain homogenates. Mol. Cell. Biochem. 140, 73-79
22. Rajkumar, D.V. and Rao, M.N.A. (1994) Dehydrozingerone and its analogues as inhibitors of nonenzymatic lipid peroxidation. Pharmazie 49, 516-519
23. 1 cells. Kidney Int. 50, 1118-1124
24. 1 cells. J. Biol. Chem. 261, 3325-3332
25. Ellmann, G.L. (1959) Tissue sulphhydryl groups. Arch. Biochem. Biophys. 82, 70-77
26. Beuge, J.A. and Aust, S.D. (1978) Microsomal lipid peroxidation. Methods Enzymol. 52, 302-]310
27. Seldak, J. and Lindsay, R.H. (1968) Estimation of total, protein-bound and nonprotein sulphhydryl groups with Ellman's reagent. Anal. Biochem. 25, 192-205
28. Bratton, A.C. and Marshall, E.K. Jr. (1939) A new coupling component for sulfanilamide determination. J. Biol. Chem. 128, 537-550
29. Knox, R.J., Friedlos, F., Lydall, D.A., and Roberts, J.J. (1986) Mechanisms of cytotoxicity of anticancer agents: evidence that cis-diaminedichloroplatinum (II) and cis-diamine (1,1-cyclobutanecarboxylato)platinum (II) differ only in the kinetics of their interaction with DNA. Cancer Res. 46, 1972-1979
30. Harder, H.C. and Rosenberg, B. (1970) Inhibitory effects of antitumor platinum compounds with DNA, RNA and protein synthesis in mammalian cells in vitro. Int. J. Cancer 6, 207-216
31. Tay, L.K., Bregman, C.L., Masters, B.A., and Williams, P.D. (1988) Effects of cis-diaminedichloroplatinum (II) on rabbit kidney in vivo: and on rabbit renal proximal tubule cells in culture. Cancer Res. 48, 2538-2543
32. Montine, T.J. and Borch, R.F. (1988) Quiescent LLC-PK1 cells as a model for nephrotoxicity and modulation by thiol rescue agents. Cancer Res. 48, 6017-6024
33. Lieberthal, W., Triaca, V., and Levine, J. (1996) Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: apoptosis vs necrosis. Am. J. Physiol. 270, F700-708
34. 2-production in cisplatin-induced nephrotoxicity. Biochem. Biophys. Res. Commun. 242, 310-312
35. Zwelling, L.A. and Kohn, K.W. (1982) Platinum complexes in Pharmacologic Principles of Cancer Treatment (Chabner, B., ed.), pp. 309-339, W.B. Saunders, Philadelphia
36. Nakano, S. and Gemba, M. (1989) Potentiation of cisplatin induced lipid peroxidation in kidney cortical slices by glutathione depletion. Jpn. J. Pharmacol. 50, 87-92
37. Elfernik, F., van der Vijgh, W.J.F., and Klein, I. (1986) Interaction of cisplatin and carboplatin with sodium thiosulphate: reaction rates and protein binding. Clin. Chem. 32, 641-645
38. Howe-Grant, M.E. and Lippard, S.J. (1980) Aqueous platinum (II) chemistry in Metal Complexes as Anticancer Agents (Sigel, H., ed.) Vol. 2, pp. 63-125, Marcel Dekker, New York
39. Har, J.R., Exon, J.H., Whonger, P.D., and Weswig, P.H. (1972) Effect of dietary selenium on N-2-fluorenylacetamide (FAA)-induced cancer in vitamin E-supplemented selenium-depleted rats. Clin. Toxicol 5, 187-194